Thanks, Rosa Hi Aaron, Interesting article re nrf2 activation
PMID: 35666500
The exact magnitude of regain with retatrutide has not been published in detail yet, but the general pattern from semaglutide and tirzepatide studies shows that approximately one-third to two-thirds of lost weight returns within 12 months of discontinuation, particularly without lifestyle modifications
Available nationwide, with appointments starting at $29, its banking on transparent pricing and intersecting primary care to differentiate itself in the expanding market
The trial missed its primary endpoint, a global statistical test of cognition and function, with a p-value of 0.70 (topline release)
In addition, we calculated I 2 statistics and p value from Cochrans Q test to measure heterogeneity among studies